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Abstract
Background: The Cuban HIV/AIDS epidemic has the lowest prevalence rate of the Caribbean region. The
objective of this paper is to give an overview of the HIV/AIDS epidemic in Cuba and to explore the reasons for
this low prevalence.
Methods: Data were obtained from the Cuban HIV/AIDS programme established in 1983. This programme has
an extensive adult HIV testing policy, including testing of all pregnant women. HIV and AIDS cases have been
recorded since 1986. Persons found to be HIV-positive are interviewed on their sexual behaviour and partners.
Tracing and voluntary testing of these partners are organised. Epidemiological description of this epidemic was
obtained from analysis of this data set. Using elementary mathematical analyses, we estimated the coverage of the
detection system (percentage of HIV-positive adults detected) and the average period between HIV infection and
detection. Estimated HIV prevalence rates were corrected to account for the coverage.
Results: HIV prevalence has increased since 1996. In 2005, the prevalence among pregnant women was 1.2 per
10,000 (16/137000). Estimated HIV prevalence among 15- to 49-year-olds was 8.1 per 10,000 (4913/6065000;
95%CI: 7.9 per 10,000 – 8.3 per 10,000). Most (77%) of the HIV-positive adults were men, most (85.1%) of the
detected HIV-positive men were reported as having sex with men (MSM), and most of the HIV-positive women
reported having had sex with MSM. The average period between HIV infection and detection was estimated to
be 2.1 years (IQR = 1.7 – 2.2 years). We estimated that, for the year 2005, 79.6% (IQR: 77.3 – 81.4%) of the HIV-
positive persons were detected.
Conclusion: MSM drive the HIV epidemic in Cuba. The extensive HIV testing policy may be an important factor
in explaining the low HIV prevalence. To reduce the HIV epidemic in Cuba, the epidemic among MSM should be
addressed. To understand this epidemic further, data on sexual behaviour should be collected. Now that
antiretroviral therapy is more widely available, the Cuban policy, based on intensive HIV testing and tracing of
partners, may be considered as a possible policy to control HIV/AIDS epidemics in other countries.
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Background
After sub-Saharan Africa, the Caribbean Basin has the sec-
ond highest rate of HIV/AIDS in the world [1]. Cuba, an
archipelago of this Caribbean Basin, comprises the island
of Cuba and several smaller islands, with 11.2 million
inhabitants (6.1 million in the age group 15–49). Life
expectancy at birth is 75 and 80 years for men and
women, respectively [2], the highest in Latin America.
The Joint United Nations Programme on HIV/AIDS
(UNAIDS) in their reports on the global HIV/AIDS epi-
demic for 2005 and 2006 estimates that national adult
HIV prevalence surpasses 1% in Barbados, Dominican
Republic and Jamaica, 2% in Trinidad and Tobago, and
exceeds 3% in Haiti and the Bahamas [3,4]. These reports
indicate that the region's epidemics are driven primarily
by heterosexual intercourse and estimate for Cuba an
adult HIV prevalence of 0.1%. This is the lowest HIV prev-
alence in the Caribbean.
The objectives of this paper are to give an overview of the
current HIV/AIDS epidemic in Cuba and to explore the
reasons for its low prevalence.
Methods
Data were obtained from the Cuban HIV/AIDS pro-
gramme established in 1983 following developments of
AIDS epidemics in other countries. The detection of the
first HIV-positive person in Cuba took place in December
1985. This person was a heterosexual male returning from
travel abroad. The first death due to AIDS occurred in
April 1986 and was officially announced in the Cuban
press soon after.
This Cuban HIV/AIDS programme included a system to
detect HIV cases from several sources. Some of these
sources started to be used at the beginning of the pro-
gramme, others were introduced later and some have
been discontinued. Since 1993, this detection system has
focused on 6 major sources. These are blood donors, per-
sons treated for other sexually transmitted infections, per-
sons admitted to hospital with suspected HIV infection or
subject to specific procedures like dialysis, persons volun-
teering to be tested, persons whose general practitioner
has recommended HIV testing and, lastly, sexual partner
tracing (see below). Other sources include testing of all
pregnant women and prison inmates.
Since 1990, each time a person is tested for HIV, she/he is
informed that such a test is going to be performed. When
a person is found to be HIV-positive, the following infor-
mation is collected and recorded in a national HIV/AIDS
database: date of detection, age, gender, area of residence,
gender of sexual partners in the past two years. A man hav-
ing sex with men (MSM) is defined in this paper as a male
reporting at least one sexual contact with another man in
the past 2 years. From 1986, a person testing HIV-positive
is interviewed by health workers using a non-anonymous
structured questionnaire. They are invited to give names
and contact details of sexual partners of the past two years.
These partners are then traced and a recommendation for
voluntary HIV testing is made [5].
Before 1994, persons who tested HIV-positive were fol-
lowed up by the national health programme in AIDS san-
atoria, which generated a lively and controversial debate
[6-8]. This programme has evolved from its original con-
ception and an outpatient care system was started in 1994
for those who wanted to leave the sanatoria. By the end of
2003, 60% of HIV-positive persons lived outside the san-
atoria [9]. Each HIV-positive person receives, either in the
sanatoria or in the outpatient system, regular counselling
on living with HIV and how to prevent the risk of trans-
mitting the virus.
AIDS cases are defined by the national health programme
as HIV-positive persons with at least one opportunistic
infection or, since the year 2000, a CD4 count of less than
200 cells/mm3. When a person is diagnosed with AIDS,
the date of diagnosis is reported to the health authorities
and added to the national HIV/AIDS database. Dates of
death are also recorded in this database.
Antiretroviral therapy (ART) became available in 2000
and today every person with AIDS or every HIV-positive
person with a CD4 count of less than 300 cells/mm3
receives ART free of charge. Pregnant women are all tested
for HIV and ART is proposed free of charge to pregnant
women who test HIV-positive in order to reduce the risk
of transmission of HIV to their child.
In this paper, we analyse HIV and AIDS cases recorded
yearly in the national HIV-AIDS database. HIV prevalence
among adults at the end of a year (y) was calculated as the
number of cases of persons living with HIV. Prevalence
rates among adults were calculated by dividing the
number of HIV cases from the Cuban HIV/AIDS database
by the adult population. Confidence intervals for preva-
lence rates were calculated assuming a binomial distribu-
tion.
In this paper, following the Cuban definition, adults were
defined as persons aged 15 years or more. The annual
prevalence rate among pregnant women was calculated as
the number of pregnant women who have tested HIV-pos-
itive in one year divided by the total number of births dur-
ing the same year.
The average interval (T) between HIV infection and detec-
tion was estimated by 2 methods. The first methodBMC Infectious Diseases 2007, 7:130 http://www.biomedcentral.com/1471-2334/7/130
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assumes a steady state. In this case, T is calculated by
dividing the number (P) of HIV-positive persons a year
(y) whose HIV infection was not already known by the
number (I) of HIV cases newly detected in the same year.
This calculation also assumes that AIDS mortality is negli-
gible during the period T. This calculation is still valid
when the relative change in HIV prevalence during T is
small (quasi steady state). T was calculated using equation
1 and the data of the national HIV-AIDS database. The fac-
tor P was estimated as the number of pregnant women
who test HIV-positive in the year y whose HIV infection
was not already recorded by the detection system. The fac-
tor I was estimated in the year y by multiplying the annual
number of HIV cases detected among women aged 15–49
by the proportion of pregnant women in the same group.
These calculations were carried out year by year in the
period 1996–2006. A mean and an interquartile range
(IQR) were calculated from these values.
When P and I are a function of time (t), P(t) is given by
the following equation:
When P(t) and I(T) are a linear function of time, this
equation gives T as:
A second estimation of T was obtained using this equation
3 applied to the period 1996–2005 with dP/dt and dI/dt
estimated by fitting a linear regression line through the
data among pregnant women as described above in the
first method. This second estimation is based on deriva-
tives and, thus, has too wide a confidence interval to be
indicated.
T0 being the incubation period, the coverage (c) can also
be estimated by the following equation:
Each year the detection system finds a fraction of the
number of HIV-positive persons not yet detected. This
fraction defined the performance (p) of the detection sys-
tem. This performance was estimated, year by year, by
dividing a number (n1) by a number (n2).
Using these values, a mean and an IQR were calculated. In
this equation, n1 is the number of HIV-positive women
given in the year y by the detection system in the age
group 15–49 weighted by the proportion of pregnant
women among the women of the same age group in the
same year. n2 is the number of HIV-positive women given
by the detection system in the year y in the age group 15–
49. This estimation is close to reality because all pregnant
women are tested for HIV. The value of p calculated using
equation 5 assumes that HIV prevalence among women
in the age group 15–49 is close to the HIV prevalence
among pregnant women of the same age.
We defined the coverage (c) of the detection system at a
given time as the percentage of persons living with HIV
that were detected before that time. This coverage was esti-
mated in the following way. At the end of a year (y), from
the data base we have the total number of cumulated
detected HIV cases (H0) and the number of new detec-
tions in the same year (Hy). Using the performance of the
detection system, we estimated the total accumulated
number of HIV infections (Ht) as Ht = H0+Hy/p. The cov-
erage of the detection system is then defined as the ratio
H0/Ht.
A mean coverage was calculated using the mean perform-
ance. An estimation of the IQR of the coverage was calcu-
lated by using the IQR of the performance. To take into
account the coverage of the detection system, a corrected
value of HIV prevalence for men and women was calcu-
lated by dividing by c, given by equation 6, the prevalence
given by the data base. We assumed that this coverage is
not dependent on gender.
The median (IQR) interval between HIV detection and
AIDS was calculated by survival analysis using the dates of
HIV detection and the dates of AIDS using data prior to
the introduction of ART in 2000.
This study has been approuved by the Ethics Committee
of the Instituto de Medicina Tropical "Pedro Kouri",
Havana Cuba in its monthly meetting of January 2005.
Results
On average 1.6 million HIV tests were performed annu-
ally in the period 2000–2005. Table 1 shows the distribu-
tion of detected HIV cases according to how they were
detected in the period 2000–2005. The HIV cases detected
by sexual partner tracing or following a visit to a general
T P
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practitioner represented 48.9% of the newly detected HIV
cases in this period.
Figure 1 shows the number of HIV infections, AIDS cases
and deaths due to AIDS detected per year from 1986 to
2005. This figure shows that the number of HIV cases
detected has increased sharply since 1996. The drop in
HIV cases in the period 1993–1996 corresponds to a
period of economic restrictions that had repercussions on
the efficiency of the detection system. In 2005, 942 HIV
infections were detected, with 887 (94.2%) among 15- to
49-year-olds. The increase in the number of AIDS cases
detected from the year 2000 could be influenced by the
introduction of ART, as patients that did not attend their
scheduled consultations started attending them to obtain
the newly available treatment, and at that time were diag-
nosed with AIDS.
Just before the introduction of ART, in the year 1999, 175
adult AIDS cases were recorded, among whom a high pro-
portion of men (76.6%). Most of these 175 cases (140,
80.0%) had already been known to be HIV-positive. In
the same year, the proportion of AIDS cases among
women already known to be HIV-positive (37/41; 90.2%)
was close to that among men (103/134; 76.9%, p = 0.075,
Fisher exact test)
Figure 2 shows the distribution of the HIV prevalence rate,
not corrected for coverage, among adults and as a function
of gender by year from 1995 to 2005. This figure shows a
constant increase of HIV prevalence since 1995. In 2005,
the uncorrected HIV prevalence was 6.4 per 10,000
(3866/6065000; 95%CI: 6.2 per 10,000 – 6.6 per
10,000).
In 2005, the female-to-male ratio among all adults was
1:5.2, so 83.8% of the HIV-positive adults were men. This
percentage was quasi-constant from 2000 to 2004 with
values of 82.7, 81.0, 86.2, 80.6 and 85.4%, respectively. In
2005, most (85.3%) of the men detected as HIV-positive
were reported as being MSM.
In the period 2000–2005, interviews were carried out with
495 women who had been found to be HIV-positive and
who represented 68.2% of those who tested HIV-positive.
The sexual partners of these women were then interviewed
as to their sexual preferences, and it was found that 70.9%
of the women in the sample had sexual partners that were
MSM.
Figure 3 shows the HIV prevalence rate among pregnant
women by year from 1992 to 2005. This prevalence rate
Uncorrected HIV prevalence among 15- to 49-year-old  adults for all (circle), for women (triangles) and for men  (squares) Figure 2
Uncorrected HIV prevalence among 15- to 49-year-old 
adults for all (circle), for women (triangles) and for men 
(squares).
0
1
2
3
4
5
6
7
8
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
YEAR
X
 
1
0
0
0
0
Table 1: Distribution of HIV cases detected according to how 
they were detected in the period 2000–2005
How detected % of total
Test recommended by general practitioners 27.1
Sexual partner tracing 21.7
Voluntary testing 12.1
Blood donors 9.7
HIV test done in hospitals 8.9
Persons with other sexually transmitted infections 8.3
Pregnant women 1.6
Other 10.6
Total 100% (n = 4276)
Number of detected HIV cases (square), AIDS cases (trian- gle) and deaths (circle) due to AIDS per year as given by the  Cuban HIV/AIDS database Figure 1
Number of detected HIV cases (square), AIDS cases (trian-
gle) and deaths (circle) due to AIDS per year as given by the 
Cuban HIV/AIDS database.
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increases as a function of time. The slope of the linear
regression line was 0.8% per year. In 2005, the HIV prev-
alence rate among pregnant women was 1.2 per 10,000
(16/137000).
Using equation 1, the average interval between HIV infec-
tion and detection was estimated to be 2.1 years (IQR =
1.7 – 2.2 years). Using equation 3, we found 2.5 years.
Assuming an incubation period of 10 years, using equa-
tion 4, these two values lead to an estimated coverage of
0.79 and 0.75, respectively.
Using equation 5, the efficiency of the detection system
for the period 1995–2005 was 52.9% (IQR: 46.3 –
59.2%). Using equation 6, the coverage of the detection
system for the year 2005 was 79.6% (IQR: 77.3 – 81.4%),
which is consistent with the high proportion of people
already detected among AIDS cases (see above). It is also
consistent with the values calculated using equation 4 (see
above).
The corrected HIV prevalence rate in 2005 among 15- to
49-year-olds was 8.1 per 10,000 (4913/6065000; 95% CI:
7.9 per 10,000 – 8.3 per 10,000).
The median interval between detection and AIDS in the
period 1995 – 2004 was 6.7 years (IQR = 6.1 – 7.2), which
when added to the estimated time lapse between infection
and detection (2.1 or 2.5 years) leads to an estimated
incubation period of 8.8 years or 9.2 years.
In 2005, 88 million condoms were made available to the
Cuban population through the retail pharmacy system.
The 2004 figure was 82 million. Another 3 million con-
doms were distributed, free of charge, through educa-
tional and prevention programmes.
Discussion
This paper shows that the HIV epidemic in Cuba is char-
acterised by a low but rising HIV prevalence and by a
majority of HIV cases among men having sex with men.
These results indicate that HIV in Cuba is different from
HIV epidemics in other Caribbean countries where the
prevalence rates are higher and where the epidemics are
driven primarily by heterosexual intercourse [3].
Several factors may have had some influence on the HIV
epidemic data reported in this paper. The detection sys-
tem has changed with time and was not fully functioning
in the period 1993–1996. The impact of these factors is in
all likelihood limited because most of the analyses pre-
sented here relate to the period 1996–2005.
Nevertheless, bias in the system of detection of HIV cases
may also have led to incorrect estimation of the epidemic.
We found this detection system's coverage to be high.
Prevalence data calculated from the Cuban HIV/AIDS pro-
gramme were corrected to take into account this coverage.
Several studies have used deterministic mathematical
models to analyse the Cuban HIV/AIDS database and epi-
demic. Using data up to 1999, a first study reported an
efficiency of 45.5% [10]. A second study, using data up to
2001, showed that the coverage is between 75% and 87%.
[11]. A third study, using data up to 2002, estimated that
it takes a mean 2.7 years to detect a person infected with
HIV [12]. These estimations are consistent with the esti-
mations given in this paper, which used the current ver-
sion of the database and elementary epidemiological
analyses.
Lastly, we cannot exclude a gender bias in the detection
system, which could have led to a differential between
coverage men and women. This differential could be due
to a differential in reporting contact details of sexual part-
ners by males and females when found to be HIV-positive.
The impact of such a phenomenon is likely small because
we found that the proportion of AIDS cases among per-
sons already known as HIV-positive was as high among
women as among men.
The low HIV prevalence rate in Cuba in comparison with
other Caribbean countries is surprising. There is no reason
to think that this is due to a late introduction of the virus
because HIV was present in Cuba at the onset of the
worldwide HIV epidemic. Two possible major explana-
tions can be given for such a minor HIV epidemic: 1) Sex-
ual behaviour may be different with less commercial sex
HIV prevalence rate in pregnant women as given by the  Cuban HIV/AIDS database Figure 3
HIV prevalence rate in pregnant women as given by the 
Cuban HIV/AIDS database. The dotted line shows the linear 
trend.
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and higher condom use, and 2) the intensive HIV testing
policy with intensive counselling and follow-up of HIV-
positive persons. More data on sexual behaviour in Cuba
and in the other Caribbean countries are needed to assess
the importance of the first possible explanation. The
importance of the second possible explanation can be dis-
cussed qualitatively. The impact of the detection system in
Cuba, which includes tracing of sexual partners, may have
played an important role by allowing the detection of
HIV-positive individuals only a couple of years after HIV
acquisition, with a follow-up reducing the transmission of
the virus to other persons.
Conclusion
Cuba's approach to the HIV epidemic is specific and has
been debated. Today, with the availability of ART, the
ways chosen by Cuba to control the HIV/AIDS epidemic
may be seen differently [13]. The intensive testing policy
may be a useful approach to control an HIV epidemic, as
a complement to other prevention approaches [14]. In
addition, it should be emphasised that the information
given to the population about the epidemic since the
death of the first person in 1986 on TV, radio and other
media may also have played a role in reducing the spread
of HIV by alerting the population. Today, special pro-
grammes designed for teenagers have regular spots on HIV
prevention and prevention of mother-to-child transmis-
sion of HIV is efficient: Cuba has a low percentage of ver-
tical transmission (12%) [15]. The rising HIV prevalence
is worrying. Despite current preventive and educational
programmes carried out among MSM groups to advise
them and to raise awareness about HIV acquisition and
transmission, the clear increase in HIV among men shows
that these programmes should be reinforced. Finally,
more data, especially on sexual behaviour, are needed to
analyse the Cuban HIV epidemic further and to gain
insight into future trends in the epidemic.
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